Clinical Trial Update: UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating expanded natural killer cell therapy for multiple myeloma, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Expanded natural killer cell therapy

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13